Lymphocyte subsets in primary immune thrombocytopenia.

Area of Science:

• Immunology
• Hematology
• Clinical Medicine

Background:

• Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts.
• Understanding the role of T-lymphocyte subsets in active ITP is crucial for diagnosis and treatment.
• Peripheral blood immunocyte subset analysis may offer insights into ITP pathogenesis.

Purpose of the Study:

• To investigate the clinical significance of T-lymphocyte subsets in adult patients with active primary immune thrombocytopenia.
• To correlate T-lymphocyte subset levels with corticosteroid treatment response in ITP.

Main Methods:

• Flow cytometry was used to detect T-lymphocyte subsets in 90 active ITP patients and 59 healthy controls.
• Patients received conventional corticosteroid therapy, with responses assessed after 3 months.

Main Results:

• Active ITP patients exhibited lower CD4 T-lymphocyte and natural killer cell levels compared to controls (P < 0.05).
• CD8 T-lymphocyte levels showed a significantly wider distribution in ITP patients (P < 0.05).
• Elevated CD4 T-cell counts were associated with a reduced response to corticosteroids (r = 0.69, P = 0.04).

Conclusions:

• T-lymphocyte subset analysis in peripheral blood may aid in the diagnosis of active ITP.
• Immunocyte subset detection could be valuable for predicting therapeutic outcomes in ITP patients.
• The findings suggest a role for T-cell dysregulation in ITP and its response to therapy.